Camlin Fine Sciences liquidity ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

2.28×	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.27×	1.27×	1.40×	1.36×	1.37×
0.75×	0.75×	0.78×	0.66×	0.65×
109	109	142	80.3	93.7
260	260	337	266	293

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CAMLINFINE₹82.32

Camlin Fine Sciences Limited

· Chemicals

₹ CrorePeersCLEAN DEEPAKNTR BAYERCROP TIRUMALCHM ATUL SHK PAUSHAKLTD ANURASMcap ₹1,581 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Altman Z-Score (Other Equity as RE)	—	—	—	—	2.28
Current Ratio	1.37	1.36	1.40	1.27	1.27
Quick Ratio	0.65	0.66	0.78	0.75	0.75
Cash, Equiv & ST Investments	93.7	80.3	142.1	108.6	108.6
Working Capital	292.8	266.3	337.2	259.9	259.9

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.